These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 24699435)
21. Diet, epigenetic, and cancer prevention. Chen J; Xu X Adv Genet; 2010; 71():237-55. PubMed ID: 20933131 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of tumor promotion by parthenolide: epigenetic modulation of p21. Ghantous A; Saikali M; Rau T; Gali-Muhtasib H; Schneider-Stock R; Darwiche N Cancer Prev Res (Phila); 2012 Nov; 5(11):1298-309. PubMed ID: 23037503 [TBL] [Abstract][Full Text] [Related]
23. Epigenetic regulation and cancer (review). Chen QW; Zhu XY; Li YY; Meng ZQ Oncol Rep; 2014 Feb; 31(2):523-32. PubMed ID: 24337819 [TBL] [Abstract][Full Text] [Related]
24. Understanding histone deacetylases in the cancer development and treatment: an epigenetic perspective of cancer chemotherapy. Ahmad M; Hamid A; Hussain A; Majeed R; Qurishi Y; Bhat JA; Najar RA; Qazi AK; Zargar MA; Singh SK; Saxena AK DNA Cell Biol; 2012 Oct; 31 Suppl 1():S62-71. PubMed ID: 22462686 [TBL] [Abstract][Full Text] [Related]
25. [Epigenetics and cancer]. Kern I; Rossier MF; Chappuis PO Rev Med Suisse; 2007 Feb; 3(100):540-2, 544-5. PubMed ID: 17410941 [TBL] [Abstract][Full Text] [Related]
26. Unraveling the epigenetic code of cancer for therapy. Smith LT; Otterson GA; Plass C Trends Genet; 2007 Sep; 23(9):449-56. PubMed ID: 17681396 [TBL] [Abstract][Full Text] [Related]
27. DNA demethylating agents and epigenetic therapy of cancer. Mani S; Herceg Z Adv Genet; 2010; 70():327-40. PubMed ID: 20920754 [TBL] [Abstract][Full Text] [Related]
28. Epigenetic cancer therapy: rationales, targets and drugs. Rius M; Lyko F Oncogene; 2012 Sep; 31(39):4257-65. PubMed ID: 22179827 [TBL] [Abstract][Full Text] [Related]
30. Pharmaco-epigenomics: discovering therapeutic approaches and biomarkers for cancer therapy. Claes B; Buysschaert I; Lambrechts D Heredity (Edinb); 2010 Jul; 105(1):152-60. PubMed ID: 20389307 [TBL] [Abstract][Full Text] [Related]
31. Valproic acid as epigenetic cancer drug: preclinical, clinical and transcriptional effects on solid tumors. Duenas-Gonzalez A; Candelaria M; Perez-Plascencia C; Perez-Cardenas E; de la Cruz-Hernandez E; Herrera LA Cancer Treat Rev; 2008 May; 34(3):206-22. PubMed ID: 18226465 [TBL] [Abstract][Full Text] [Related]
33. Effects of phytochemicals on ionization radiation-mediated carcinogenesis and cancer therapy. Nambiar D; Rajamani P; Singh RP Mutat Res; 2011; 728(3):139-57. PubMed ID: 22030216 [TBL] [Abstract][Full Text] [Related]
34. Histone deacetylation in epigenetics: an attractive target for anticancer therapy. Mai A; Massa S; Rotili D; Cerbara I; Valente S; Pezzi R; Simeoni S; Ragno R Med Res Rev; 2005 May; 25(3):261-309. PubMed ID: 15717297 [TBL] [Abstract][Full Text] [Related]
36. Antitumor promoting potential of selected phytochemicals derived from spices: a review. Rajput S; Mandal M Eur J Cancer Prev; 2012 Mar; 21(2):205-15. PubMed ID: 21876437 [TBL] [Abstract][Full Text] [Related]
37. Antioxidants: friends or foe in prevention or treatment of cancer: the debate of the century. Saeidnia S; Abdollahi M Toxicol Appl Pharmacol; 2013 Aug; 271(1):49-63. PubMed ID: 23680455 [TBL] [Abstract][Full Text] [Related]
38. Epigenetic biomarkers for human cancer: the time is now. Mulero-Navarro S; Esteller M Crit Rev Oncol Hematol; 2008 Oct; 68(1):1-11. PubMed ID: 18430583 [TBL] [Abstract][Full Text] [Related]
39. Epigenetic mechanisms in anti-cancer actions of bioactive food components--the implications in cancer prevention. Stefanska B; Karlic H; Varga F; Fabianowska-Majewska K; Haslberger A Br J Pharmacol; 2012 Sep; 167(2):279-97. PubMed ID: 22536923 [TBL] [Abstract][Full Text] [Related]
40. Clinical implications of epigenetic alterations in human thoracic malignancies: epigenetic alterations in lung cancer. Shinjo K; Kondo Y Methods Mol Biol; 2012; 863():221-39. PubMed ID: 22359296 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]